{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T21:26:37Z","timestamp":1765142797685},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1007\/s11883-003-0080-4","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T01:09:52Z","timestamp":1180055392000},"page":"101-105","source":"Crossref","is-referenced-by-count":27,"title":["C-reactive protein: The pawn has been promoted to queen"],"prefix":"10.1007","volume":"5","author":[{"given":"Edward T. H.","family":"Yeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Palusinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"80_CR1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1084\/jem.52.4.561","volume":"52","author":"WS Tillett","year":"1930","unstructured":"Tillett WS, Francis T Jr: Serological reactions in pneumonia with a non-protein somatic fraction of pneumonococcus. J Exp Med 1930, 52: 561\u2013571.","journal-title":"J Exp Med"},{"key":"80_CR2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0969-2126(99)80023-9","volume":"7","author":"D Thompson","year":"1999","unstructured":"Thompson D, Pepys MB, Wood SP: The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure Fold Des 1999, 7: 169\u2013177.","journal-title":"Structure Fold Des"},{"key":"80_CR3","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1002\/j.1460-2075.1989.tb08554.x","volume":"8","author":"U Ganter","year":"1989","unstructured":"Ganter U, Arcone R, Toniatti C, et al.: Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6. Embolism J 1989, 8: 3773\u20133779.","journal-title":"Embolism J"},{"key":"80_CR4","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999, 340: 448\u2013454.","journal-title":"N Engl J Med"},{"key":"80_CR5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0021-9150(01)00703-1","volume":"162","author":"RY Zee","year":"2002","unstructured":"Zee RY, Ridker PM: Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 2002, 162: 217\u2013219.","journal-title":"Atherosclerosis"},{"key":"80_CR6","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0008-6363(01)00534-X","volume":"53","author":"MA Vickers","year":"2002","unstructured":"Vickers MA, Green FR, Terry C, et al.: Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res 2002, 53: 1029\u20131034.","journal-title":"Cardiovasc Res"},{"key":"80_CR7","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0002-9440(10)64051-5","volume":"158","author":"K Yasojima","year":"2001","unstructured":"Yasojima K, Schwab C, McGeer EG, et al.: Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 2001, 158: 1039\u20131051.","journal-title":"Am J Pathol"},{"key":"80_CR8","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/clinchem\/47.3.444","volume":"47","author":"IS Ockene","year":"2001","unstructured":"Ockene IS, Matthews CE, Rifai N, et al.: Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem 2001, 47: 444\u2013450.","journal-title":"Clin Chem"},{"key":"80_CR9","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0140-6736(96)07591-5","volume":"349","author":"F Haverkate","year":"1997","unstructured":"Haverkate F, Thompson SG, Pyke SD, et al.: Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997, 349: 462\u2013466.","journal-title":"Lancet"},{"key":"80_CR10","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0735-1097(98)00136-3","volume":"31","author":"DA Morrow","year":"1998","unstructured":"Morrow DA, Rifai N, Antman EM, et al.: C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1998, 31: 1460\u20131465.","journal-title":"J Am Coll Cardiol"},{"key":"80_CR11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199408183310701","volume":"331","author":"G Liuzzo","year":"1994","unstructured":"Liuzzo G, Biasucci LM, Gallimore JR, et al.: The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994, 331: 417\u2013424.","journal-title":"N Engl J Med"},{"key":"80_CR12","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0002-8703(96)90164-7","volume":"131","author":"S Ueda","year":"1996","unstructured":"Ueda S, Ikeda U, Yamamoto K, et al.: C-reactive protein as a predictor of cardiac rupture after acute myocardial infarction. Am Heart J 1996, 131: 857\u2013860.","journal-title":"Am Heart J"},{"key":"80_CR13","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.CIR.98.9.839","volume":"98","author":"PM Ridker","year":"1998","unstructured":"Ridker PM, Rifai N, Pfeffer MA, et al.: Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation 1998, 98: 839\u2013844.","journal-title":"Circulation"},{"key":"80_CR14","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/hc3401.095074","volume":"104","author":"DP Chew","year":"2001","unstructured":"Chew DP, Bhatt DL, Robbins MA, et al.: Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation 2001, 104: 992\u2013997.","journal-title":"Circulation"},{"key":"80_CR15","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/hc0702.104126","volume":"105","author":"E Rossi","year":"2002","unstructured":"Rossi E, Biasucci LM, Citterio F, et al.: Risk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive protein. Circulation 2002, 105: 800\u2013803.","journal-title":"Circulation"},{"key":"80_CR16","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/S0735-1097(99)00348-4","volume":"34","author":"A Buffon","year":"1999","unstructured":"Buffon A, Liuzzo G, Biasucci LM, et al.: Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 1999, 34: 1512\u20131521.","journal-title":"J Am Coll Cardiol"},{"key":"80_CR17","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1161\/01.CIR.103.13.1813","volume":"103","author":"PM Ridker","year":"2001","unstructured":"Ridker PM: High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001, 103: 1813\u20131818.","journal-title":"Circulation"},{"key":"80_CR18","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMoa021993","volume":"347","author":"PM Ridker","year":"2002","unstructured":"Ridker PM, Rifai N, Rose L, et al.: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002, 347: 1557\u20131565.","journal-title":"N Engl J Med"},{"key":"80_CR19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/hy0202.104270","volume":"39","author":"JL Abramson","year":"2002","unstructured":"Abramson JL, Weintraub WS, Vaccarino V: Association between pulse pressure and C-reactive protein among apparently healthy US adults. Hypertension 2002, 39: 197\u2013202.","journal-title":"Hypertension"},{"key":"80_CR20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.286.3.327","volume":"286","author":"AD Pradhan","year":"2001","unstructured":"Pradhan AD, Manson JE, Rifai N, et al.: C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001, 286: 327\u2013334.","journal-title":"JAMA"},{"key":"80_CR21","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/hc0502.103331","volume":"105","author":"A Tchernof","year":"2002","unstructured":"Tchernof A, Nolan A, Sites CK, et al.: Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation 2002, 105: 564\u2013569.","journal-title":"Circulation"},{"key":"80_CR22","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1161\/hc4901.101760","volume":"104","author":"MK Chung","year":"2001","unstructured":"Chung MK, Martin DO, Sprecher D, et al.: C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001, 104: 2886\u20132891.","journal-title":"Circulation"},{"key":"80_CR23","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1161\/01.CIR.0000018948.95175.03","volume":"105","author":"AS Shamsuzzaman","year":"2002","unstructured":"Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al.: Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002, 105: 2462\u20132464.","journal-title":"Circulation"},{"key":"80_CR24","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.10265","volume":"52","author":"R Schmidt","year":"2002","unstructured":"Schmidt R, Schmidt H, Curb JD, et al.: Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol 2002, 52: 168\u2013174.","journal-title":"Ann Neurol"},{"key":"80_CR25","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1093\/clinchem\/48.10.1781","volume":"48","author":"JK Pai","year":"2002","unstructured":"Pai JK, Curhan GC, Cannuscio CC, et al.: Stability of novel plasma markers associated with cardiovascular disease: processing within 36 hours of specimen collection. Clin Chem 2002, 48: 1781\u20131784.","journal-title":"Clin Chem"},{"key":"80_CR26","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.4049\/jimmunol.112.6.2135","volume":"112","author":"MH Kaplan","year":"1974","unstructured":"Kaplan MH, Volanakis JE: Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin. J Immunol 1974, 112: 2135\u20132147.","journal-title":"J Immunol"},{"key":"80_CR27","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/01.ATV.20.9.2094","volume":"20","author":"M Torzewski","year":"2000","unstructured":"Torzewski M, Rist C, Mortensen RF, et al.: C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 2000, 20: 2094\u20132099.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"80_CR28","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1182\/blood.V82.2.513.513","volume":"82","author":"J Cermak","year":"1993","unstructured":"Cermak J, Key NS, Bach RR, et al.: C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993, 82: 513\u2013520.","journal-title":"Blood"},{"key":"80_CR29","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1161\/01.CIR.102.18.2165","volume":"102","author":"V Pasceri","year":"2000","unstructured":"Pasceri V, Willerson JT, Yeh ET: Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000, 102: 2165\u20132168.","journal-title":"Circulation"},{"key":"80_CR30","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1161\/01.CIR.103.21.2531","volume":"103","author":"V Pasceri","year":"2001","unstructured":"Pasceri V, Cheng JS, Willerson JT, et al.: Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 2001, 103: 2531\u20132534.","journal-title":"Circulation"},{"key":"80_CR31","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1161\/01.CIR.0000015126.83143.B4","volume":"105","author":"S Verma","year":"2002","unstructured":"Verma S, Li SH, Badiwala MV, et al.: Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 2002, 105: 1890\u20131896.","journal-title":"Circulation"},{"key":"80_CR32","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/01.CIR.103.9.1194","volume":"103","author":"TP Zwaka","year":"2001","unstructured":"Zwaka TP, Hombach V, Torzewski J: C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 2001, 103: 1194\u20131197.","journal-title":"Circulation"},{"key":"80_CR33","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/01.CIR.0000029802.88087.5E","volume":"106","author":"S Verma","year":"2002","unstructured":"Verma S, Wang CH, Li SH, et al.: A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002, 106: 913\u2013919.","journal-title":"Circulation"},{"key":"80_CR34","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1161\/01.CIR.0000033116.22237.F9","volume":"106","author":"SK Venugopal","year":"2002","unstructured":"Venugopal SK, Devaraj S, Yuhanna I, et al.: Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002, 106: 1439\u20131441.","journal-title":"Circulation"},{"key":"80_CR35","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1161\/01.CIR.104.9.974","volume":"104","author":"ET Yeh","year":"2001","unstructured":"Yeh ET, Anderson HV, Pasceri V, et al.: C-reactive protein: linking inflammation to cardiovascular complications. Circulation 2001, 104: 974\u2013975.","journal-title":"Circulation"},{"key":"80_CR36","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1161\/01.CIR.100.21.2124","volume":"100","author":"V Pasceri","year":"1999","unstructured":"Pasceri V, Yeh ET: A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation 1999, 100: 2124\u20132126.","journal-title":"Circulation"},{"key":"80_CR37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/01.CIR.95.1.97","volume":"95","author":"WK Lagrand","year":"1997","unstructured":"Lagrand WK, Niessen HW, Wolbink GJ, et al.: C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation 1997, 95: 97\u2013103.","journal-title":"Circulation"},{"key":"80_CR38","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1084\/jem.190.12.1733","volume":"190","author":"M Griselli","year":"1999","unstructured":"Griselli M, Herbert J, Hutchinson WL, et al.: C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med 1999, 190: 1733\u20131740.","journal-title":"J Exp Med"},{"key":"80_CR39","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1128\/IAI.68.10.5652-5656.2000","volume":"68","author":"AJ Szalai","year":"2000","unstructured":"Szalai AJ, VanCott JL, McGhee JR, et al.: Human C-reactive protein is protective against fatal Salmonella enterica serovar typhimurium infection in transgenic mice. Infect Immun 2000, 68: 5652\u20135656.","journal-title":"Infect Immun"},{"key":"80_CR40","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1073\/pnas.94.6.2575","volume":"94","author":"D Xia","year":"1997","unstructured":"Xia D, Samols D: Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia. Proc Natl Acad Sci U S A 1997, 94: 2575\u20132580.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"80_CR41","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1172\/JCI119561","volume":"100","author":"C Zouki","year":"1997","unstructured":"Zouki C, Beauchamp M, Baron C, et al.: Prevention of in vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein. J Clin Invest 1997, 100: 522\u2013529.","journal-title":"J Clin Invest"},{"key":"80_CR42","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1164\/ajrccm.153.3.8630558","volume":"153","author":"N Ahmed","year":"1996","unstructured":"Ahmed N, Thorley R, Xia D, et al.: Transgenic mice expressing rabbit C-reactive protein exhibit diminished chemotactic factor-induced alveolitis. Am J Respir Crit Care Med 1996, 153: 1141\u20131147.","journal-title":"Am J Respir Crit Care Med"},{"key":"80_CR43","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0049-3848(91)90655-G","volume":"61","author":"JG Filep","year":"1991","unstructured":"Filep JG, Herman F, Kelemen E, et al.: C-reactive protein inhibits binding of platelet-activating factor to human platelets. Thromb Res 1991, 61: 411\u2013421.","journal-title":"Thromb Res"},{"key":"80_CR44","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1084\/jem.192.9.1353","volume":"192","author":"D Gershov","year":"2000","unstructured":"Gershov D, Kim S, Brot N, et al.: C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J Exp Med 2000, 192: 1353\u20131364.","journal-title":"J Exp Med"},{"key":"80_CR45","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/ajcn\/75.3.492","volume":"75","author":"S Liu","year":"2002","unstructured":"Liu S, Manson JE, Buring JE, et al.: Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr 2002, 75: 492\u2013498.","journal-title":"Am J Clin Nutr"},{"key":"80_CR46","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0140-6736(00)04170-2","volume":"357","author":"A Imhof","year":"2001","unstructured":"Imhof A, Froehlich M, Brenner H, et al.: Effect of alcohol consumption on systemic markers of inflammation. Lancet 2001, 357: 763\u2013767.","journal-title":"Lancet"},{"key":"80_CR47","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1046\/j.1365-2362.2000.00738.x","volume":"30","author":"MA Crook","year":"2000","unstructured":"Crook MA, Scott DA, Stapleton JA, et al.: Circulating concentrations of C-reactive protein and total sialic acid in tobacco smokers remain unchanged following one year of validated smoking cessation. Eur J Clin Invest 2000, 30: 861\u2013865.","journal-title":"Eur J Clin Invest"},{"key":"80_CR48","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/aje\/153.3.242","volume":"153","author":"D Geffken","year":"2001","unstructured":"Geffken D, Cushman M, Burke G, et al.: Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol 2001, 153: 242\u2013250.","journal-title":"Am J Epidemiol"},{"key":"80_CR49","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0002-9149(01)01909-9","volume":"88","author":"AJ Siegel","year":"2001","unstructured":"Siegel AJ, Stec JJ, Lipinska I, et al.: Effect of marathon running on inflammatory and hemostatic markers. Am J Cardiol 2001, 88: 918\u2013920.","journal-title":"Am J Cardiol"},{"key":"80_CR50","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/01.CIR.100.8.793","volume":"100","author":"I Ikonomidis","year":"1999","unstructured":"Ikonomidis I, Andreotti F, Economou E, et al.: Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 1999, 100: 793\u2013798.","journal-title":"Circulation"},{"key":"80_CR51","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","volume":"336","author":"PM Ridker","year":"1997","unstructured":"Ridker PM, Cushman M, Stampfer MJ, et al.: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997, 336: 973\u2013979.","journal-title":"N Engl J Med"},{"key":"80_CR52","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.100.3.230","volume":"100","author":"PM Ridker","year":"1999","unstructured":"Ridker PM, Rifai N, Pfeffer MA, et al.: Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation 1999, 100: 230\u2013235.","journal-title":"Circulation"},{"key":"80_CR53","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJM200106283442601","volume":"344","author":"PM Ridker","year":"2001","unstructured":"Ridker PM, Rifai N, Clearfield M, et al.: Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001, 344: 1959\u20131965.","journal-title":"N Engl J Med"},{"key":"80_CR54","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1161\/01.CIR.0000029743.68247.31","volume":"106","author":"JK Plenge","year":"2002","unstructured":"Plenge JK, Hernandez TL, Weil KM, et al.: Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction. Circulation 2002, 106: 1447\u20131452.","journal-title":"Circulation"},{"key":"80_CR55","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1053\/euhj.2000.2475","volume":"21","author":"RR Azar","year":"2000","unstructured":"Azar RR, Rinfret S, Theroux P, et al.: A randomized placebo-controlled trial to assess the efficacy of antiinflammatory therapy with methylprednisolone in unstable angina (MUNA trial). Eur Heart J 2000, 21: 2026\u20132032.","journal-title":"Eur Heart J"},{"key":"80_CR56","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"A Gebbie","year":"2002","unstructured":"Gebbie A: Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women\u2019s Health Initiative Randomized Controlled Trial. Writing Group for the Women\u2019s Health Initiative# 10; Investigators. JAMA 2002, 288: 321\u2013333.","journal-title":"JAMA"},{"key":"80_CR57","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1055\/s-0037-1616085","volume":"86","author":"GD Lowe","year":"2001","unstructured":"Lowe GD, Upton MN, Rumley A, et al.: Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t-PA, PAI and C-reactive protein--a cross-sectional population survey. Thromb Haemost 2001, 86: 550\u2013556.","journal-title":"Thromb Haemost"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-003-0080-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-003-0080-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-003-0080-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:09:54Z","timestamp":1683850194000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-003-0080-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["80"],"URL":"https:\/\/doi.org\/10.1007\/s11883-003-0080-4","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}